Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward as Optibrium™, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project. The program will see Optibrium, which creates software to improve the efficiency and productivity of drug discovery, and Intellegens, a spin out from the University of Cambridge which is focused on a specific form of AI called ‘deep learning’, work with Medicines Discovery Catapult over the next two years...
The organization zooms in on Brexit product recalls and complex supply chains. NSF International, a global public health and safety organisation, will present its worldwide pharmaceutical consulting, auditing and training capabilities at CPhI 2018 at stand 3G63, Hall 3. With the pharmaceutical and biotech industries facing a wide range of challenges – from the ever-changing regulatory landscape to complex supply chains in an uncertain global environment....
Life science research tools one-stop shop, Antibodies.com, has appointed Dr Claire Button as its CEO to develop and execute its global growth strategy. CEO appointment marks a step change in growth strategy as Antibodies.com aims to become a market-leading global supplier of life science research tools....
ASTM International, a global standards organization, announced that it is a supporting partner of ARABLAB 2019, March 12-14, at the Dubai International Convention and Exhibition Centre. ARABLAB is considered the largest global trade show for laboratory science and instrumentation, with an expected 10,000 visitors from over 100 countries....
Lab Innovations, the UK’s only trade show dedicated to the laboratory industry, has announced the programme for its 2018 open conference streams, complementing its showcase of lab products, technologies and services. The laboratory industry is constantly evolving with new technologies, regulations and ways of working, and visitors can keep up-to-date with over 35 hours of CPD-accredited content.
Nightingale Health, the Finnish innovator of an internationally recognized blood biomarker technology for studying chronic diseases, will perform large-scale metabolic profiling of the Mexico City Prospective Study cohort by analyzing the biomarker profiles of blood samples from a cohort of 150,000 study participants....
Flow chemistry engineering specialists Vapourtec have strengthened their presence across Europe with the signing of a distribution deal with Belgium-based Analis. Analis Sales and Marketing Manager Ken De Roover commented: “We are delighted to strengthen our chemical synthesis portfolio with Vapourtec and will be distributing their full range of flow...
Founder and Chairman, Dr David Taylor, of Guildford based MR Solutions has been shortlisted as an Innovation Entrepreneur of the Year for London and the South East in the 2018 NatWest Great British Entrepreneur Awards. The awards have had a record number of entries with businesses from across the south east vying for a place on the shortlist...
Telstar has delivered a total of six highcontainment multi-chamber, multi-functionalisolators to the Finnish pharmaceutical Orion. Pharmaceutical company Orion entrusted Telstar as a specialized partner in containment technology to supply various isolators to sites in Finland during the last five years. All of the containment isolators were designed and manufactured by Telstar in the United Kingdom.....
DefiniGEN, the world leader in human iPSC differentiation and disease modelling, announces the appointment of Professor Sir John Savill as a Non-Executive Director of the Board. Sir John will bring his expertise in translational science to DefiniGEN enabling the company to accelerate the development of new products and services which can improve the efficiency and economics of drug development....
Lunaphore Technologies SA, a Swiss Company developing innovative next-generation devices for cancer tissue diagnostics, and A. Menarini Diagnostics S.r.l., one of Europe’s leading diagnostic solution providers and part of the Menarini Group, jointly announce the start of a strategic partnership bringing to the market a new and innovative system, using Lunaphore’s technology....
Evotec AG has announced a strategic alliance with Novo Nordisk to discover and develop novel small molecule therapies to treat patients suffering from diabetes and obesity as well as co-morbidities such as nonalcoholic steatohepatitis ("NASH"), cardiovascular diseases, and diabetic kidney disease. Evotec will apply its drug discovery platform, especially in ligand-based design...
Optibrium™, a developer of software for drug discovery, has announced it had signed a collaboration agreement with Intellegens, a company developing novel artificial intelligence (AI) software. The collaboration will provide Optibrium clients with access to advanced, proprietary deep learning methods that will extend and improve predictive models to guide the more efficient design and selection of high quality drug candidates.
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that CENTOGENE AG, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, and Evotec entered into a global strategic collaboration agreement for joint drug discovery projects, developing compounds to treat rare genetic diseases. Evotec and CENTOGENE initiated the collaboration to develop a...
Inoviem Scientific, a Contract Research Biotech (CRB), announces a service-based partnership with XoNovo, a preclinical-stage biopharmaceutical company developing a proprietary small molecule for the treatment of neurodegenerative diseases. Financial terms of the partnership were not disclosed. The partnership aims to generate crucial information concerning...
Schauenburg Analytics, parent company of Markes International and SepSolve Analytical, is set to officially open new state-of-the-art laboratories and training facilities in Offenbach am Main, Germany, on 18 September 2018. Both Markes International and SepSolve Analytical are undergoing rapid expansion, with Markes manufacturing instrumentation for thermal desorption and related sampling techniques....
Evotec AG has announced that CHDI Foundation, Inc. has extended its collaboration with Evotec through to 2023. Over this period, CHDI may fund up to 75 full-time scientists at Evotec. The collaboration was initiated in 2006 and has grown considerably over this period to fully utilise Evotec's best-in-class integrated neuroscience platform....
Sartorius Stedim Biotech a leading international supplier for the biopharmaceutical industry, and Repligen Corporation a global life sciences company focused on bioprocessing technologies, have entered into a collaboration agreement to integrate Repligen’s XCell™ ATF cell retention control technology into SSB’s BIOSTAT® STR large-scale single-use bioreactors...
First Minister Nicola Sturgeon today convened industry, academic and clinical experts in Precision Medicine from across Scotland and across the globe, bringing together the sector to declare its intention to lead the world in this exciting new development. Scotland’s Precision Medicine Summit, which was held in Perth, was co-chaired by University of Glasgow....
Clinithink has been selected to receive the RARE Champion of Hope – Collaborations in Science and Technology award at the 7th Annual RARE Patient Advocacy Summit. Over 200 individuals and organizations worldwide were nominated by their peers for a RARE Champion of Hope award...
Laborama will celebrate its 20th edition in 2019 in a new location. After more than 10 years in Brussels Kart Expo, Laborama will call Palace 3 of Brussels Expo its new home. Over the years, Laborama has grown to become the largest trade fair for the laboratory sector in Belgium and Luxembourg...
BioAscent Discovery Limited has announced the appointments of Angus Morrison, PhD, as Director of Chemistry and Stuart McElroy, PhD,as Director of Biosciences, to oversee the development and delivery of BioAscent’s integrated drug discovery services....
Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward as Optibrium™, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project. The program will see Optibrium, which creates software to improve the efficiency and productivity of drug discovery, and Intellegens, a spin out from the University of Cambridge which is focused on a specific form of AI called ‘deep learning’, work with Medicines Discovery Catapult over the next two years...
The organization zooms in on Brexit product recalls and complex supply chains. NSF International, a global public health and safety organisation, will present its worldwide pharmaceutical consulting, auditing and training capabilities at CPhI 2018 at stand 3G63, Hall 3. With the pharmaceutical and biotech industries facing a wide range of challenges – from the ever-changing regulatory landscape to complex supply chains in an uncertain global environment....
Life science research tools one-stop shop, Antibodies.com, has appointed Dr Claire Button as its CEO to develop and execute its global growth strategy. CEO appointment marks a step change in growth strategy as Antibodies.com aims to become a market-leading global supplier of life science research tools....
ASTM International, a global standards organization, announced that it is a supporting partner of ARABLAB 2019, March 12-14, at the Dubai International Convention and Exhibition Centre. ARABLAB is considered the largest global trade show for laboratory science and instrumentation, with an expected 10,000 visitors from over 100 countries....
Lab Innovations, the UK’s only trade show dedicated to the laboratory industry, has announced the programme for its 2018 open conference streams, complementing its showcase of lab products, technologies and services. The laboratory industry is constantly evolving with new technologies, regulations and ways of working, and visitors can keep up-to-date with over 35 hours of CPD-accredited content.
Nightingale Health, the Finnish innovator of an internationally recognized blood biomarker technology for studying chronic diseases, will perform large-scale metabolic profiling of the Mexico City Prospective Study cohort by analyzing the biomarker profiles of blood samples from a cohort of 150,000 study participants....
Flow chemistry engineering specialists Vapourtec have strengthened their presence across Europe with the signing of a distribution deal with Belgium-based Analis. Analis Sales and Marketing Manager Ken De Roover commented: “We are delighted to strengthen our chemical synthesis portfolio with Vapourtec and will be distributing their full range of flow...
Founder and Chairman, Dr David Taylor, of Guildford based MR Solutions has been shortlisted as an Innovation Entrepreneur of the Year for London and the South East in the 2018 NatWest Great British Entrepreneur Awards. The awards have had a record number of entries with businesses from across the south east vying for a place on the shortlist...
Telstar has delivered a total of six highcontainment multi-chamber, multi-functionalisolators to the Finnish pharmaceutical Orion. Pharmaceutical company Orion entrusted Telstar as a specialized partner in containment technology to supply various isolators to sites in Finland during the last five years. All of the containment isolators were designed and manufactured by Telstar in the United Kingdom.....
DefiniGEN, the world leader in human iPSC differentiation and disease modelling, announces the appointment of Professor Sir John Savill as a Non-Executive Director of the Board. 
Lunaphore Technologies SA, a Swiss Company developing innovative next-generation devices for cancer tissue diagnostics, and A. Menarini Diagnostics S.r.l., one of Europe’s leading diagnostic solution providers and part of the Menarini Group, jointly announce the start of a strategic partnership bringing to the market a new and innovative system, using Lunaphore’s technology....
Evotec AG has announced a strategic alliance with Novo Nordisk to discover and develop novel small molecule therapies to treat patients suffering from diabetes and obesity as well as co-morbidities such as nonalcoholic steatohepatitis ("NASH"), cardiovascular diseases, and diabetic kidney disease. Evotec will apply its drug discovery platform, especially in ligand-based design...
Optibrium™, a developer of software for drug discovery, has announced it had signed a collaboration agreement with Intellegens, a company developing novel artificial intelligence (AI) software. The collaboration will provide Optibrium clients with access to advanced, proprietary deep learning methods that will extend and improve predictive models to guide the more efficient design and selection of high quality drug candidates. 
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that CENTOGENE AG, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, and Evotec entered into a global strategic collaboration agreement for joint drug discovery projects, developing compounds to treat rare genetic diseases. Evotec and CENTOGENE initiated the collaboration to develop a...
Inoviem Scientific, a Contract Research Biotech (CRB), announces a service-based partnership with XoNovo, a preclinical-stage biopharmaceutical company developing a proprietary small molecule for the treatment of neurodegenerative diseases. Financial terms of the partnership were not disclosed. The partnership aims to generate crucial information concerning...
Schauenburg Analytics, parent company of Markes International and SepSolve Analytical, is set to officially open new state-of-the-art laboratories and training facilities in Offenbach am Main, Germany, on 18 September 2018. Both Markes International and SepSolve Analytical are undergoing rapid expansion, with Markes manufacturing instrumentation for thermal desorption and related sampling techniques....
Sartorius Stedim Biotech a leading international supplier for the biopharmaceutical industry, and Repligen Corporation a global life sciences company focused on bioprocessing technologies, have entered into a collaboration agreement to integrate Repligen’s XCell™ ATF cell retention control technology into SSB’s BIOSTAT® STR large-scale single-use bioreactors...
First Minister Nicola Sturgeon today convened industry, academic and clinical experts in Precision Medicine from across Scotland and across the globe, bringing together the sector to declare its intention to lead the world in this exciting new development. Scotland’s Precision Medicine Summit, which was held in Perth, was co-chaired by University of Glasgow....
Clinithink has been selected to receive the RARE Champion of Hope – Collaborations in Science and Technology award at the 7th Annual RARE Patient Advocacy Summit. Over 200 individuals and organizations worldwide were nominated by their peers for a RARE Champion of Hope award...
Laborama will celebrate its 20th edition in 2019 in a new location. After more than 10 years in Brussels Kart Expo, Laborama will call Palace 3 of Brussels Expo its new home. Over the years, Laborama has grown to become the largest trade fair for the laboratory sector in Belgium and Luxembourg...
BioAscent Discovery Limited has announced the appointments of